Skip to content
All comparisons

Side by side

Blue Morpho vs Temple of the Way of Light

Blue Morpho and Temple of the Way of Light, compared on what each publishes: price, programme length, screening, staff, the law where it operates and its public record. Neither centre has paid to appear here, and this page makes no recommendation.

Blue Morpho compared with Temple of the Way of Light
Blue MorphoTemple of the Way of Light
LocationNear Iquitos, Loreto; also Sacred Valley, Cusco, PeruNear Iquitos, Loreto, Peru
MedicineAyahuascaAyahuasca
Legal footingLegal in PeruLegal in Peru
Lowest published price$1,998 (read 28 Sep 2026)$3,330 (read 28 Sep 2026)
Programme lengthNot published7 to 11 nights
Ceremonies or sessions2, 3, 4 per programme4, 6 per programme
Medical screeningDescribed on its websiteDescribed on its website
Asks about antidepressantsNot statedYes, stated
Team and medical staffMaestro Hamilton Souther (founder).Shipibo healers (onanya) lead ceremonies with facilitators present.
LicenceNo licensing regime appliesNo licensing regime applies
Founded20032007
Public recordNone foundNone found
Where these facts come fromDetails from the centre's own website and independent sources, read 28 Sep 2026. Full profile and sourcesDetails from the centre's own website and independent sources, read 28 Sep 2026. Full profile and sources

Questions and answers

Which is cheaper, Blue Morpho or Temple of the Way of Light?
By lowest published price, Blue Morpho (from $1,998) is cheaper than Temple of the Way of Light (from $3,330). These are each centre's own starting prices, read 28 Sep 2026 and 28 Sep 2026; programmes differ in length and what is included, so compare like with like.Sources: Blue Morpho website, 28 Sep 2026; Temple of the Way of Light website, 28 Sep 2026
Is ayahuasca legal where both centres operate?
Traditional ayahuasca use is protected as national cultural heritage; there is no licensing regime for retreats.The law in each place, cited

The dispatch

Laws change. Centres change. Know before you book.

A brief, sent only in weeks when something changes: jurisdictions that shifted, listings added or revised, and the research worth reading. No hype, no sourcing talk.

Educational only. Not medical advice. Unsubscribe any time.